Valuation: Cogstate Limited

Market Cap 46Cr 33Cr 28Cr 27Cr 24Cr 46Cr 3.15TCr 313.65Cr 122.92Cr 1.58TCr 123.54Cr 120.86Cr 5.25TCr P/E 2026
27.9x
P/E 2027 * 22.1x
Enterprise Value 41Cr 29Cr 25Cr 23Cr 21Cr 40Cr 2.76TCr 274.99Cr 107.77Cr 1.38TCr 108.31Cr 105.96Cr 4.6TCr EV / Sales 2026
5.42x
EV / Sales 2027 * 3.8x
Free-Float
54.18%
Yield 2026 *
1.2%
Yield 2027 * 2.16%
1 day+6.41%
1 week+5.64%
Current month+16.20%
1 month+5.64%
3 months+14.82%
6 months+22.57%
Current year+28.54%
1 week 2.62
Extreme 2.62
2.95
1 month 2.42
Extreme 2.42
2.95
Current year 2.01
Extreme 2.01
3.01
1 year 1.65
Extreme 1.65
3.01
3 years 0.8
Extreme 0.795
3.01
5 years 0.8
Extreme 0.795
3.01
10 years 0.16
Extreme 0.155
3.01
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer - 17/12/1999
Chief Executive Officer - 01/12/2005
Director of Finance/CFO - 01/02/2021
Director TitleAgeSince
Director/Board Member - 01/03/2011
Chairman 67 03/11/2009
Director/Board Member - 20/01/2017
Date Insider Type Main position Quantity % Market Cap.
24/12/25 Buy

Director

10,183 0.0059%
02/11/25 Free

Chief Executive Officer

5,91,822 0.3448%
19/10/25 Fiscal year

Chief Executive Officer

3,99,500 0.2324%
Change 5-day change 1-year change 3-year change Capi.($)
+6.23%+5.64%+73.95%+104.58% 33Cr
-0.11%-1.67%+1.80%+19.90% 4.86TCr
+1.89%+5.08%+492.59%+629.24% 4.63TCr
+1.83%+2.75%+15.61%+91.22% 4.2TCr
-0.50%-1.56%+24.67%+12.17% 3.95TCr
-2.74%-7.13%+18.72%+49.04% 3.17TCr
-1.14%-2.51%+27.52%+136.42% 1.65TCr
+0.59%-2.25% - - 1.63TCr
-0.49%-0.34%+3.45%+29.14% 1.4TCr
-2.60%-1.00%+77.85%+40.37% 1.33TCr
Average +0.31%-0.35%+81.79%+123.56% 2.69TCr
Weighted average by Cap. +0.01%-0.35%+105.75%+155.35%

Financials

2026 2027 *
Net sales 8.69Cr 6.17Cr 5.33Cr 5.01Cr 4.56Cr 8.57Cr 591.04Cr 59Cr 23Cr 295.6Cr 23Cr 23Cr 984.61Cr 11Cr 7.51Cr 6.49Cr 6.11Cr 5.55Cr 10Cr 719.84Cr 72Cr 28Cr 360.02Cr 28Cr 28Cr 1.2TCr
Net income 1.69Cr 1.2Cr 1.04Cr 97.43L 88.55L 1.67Cr 114.87Cr 11Cr 4.48Cr 57Cr 4.5Cr 4.4Cr 191.37Cr 2.15Cr 1.53Cr 1.32Cr 1.24Cr 1.13Cr 2.12Cr 146.26Cr 15Cr 5.7Cr 73Cr 5.73Cr 5.61Cr 243.66Cr
Net Debt -5.72Cr -4.06Cr -3.5Cr -3.3Cr -3Cr -5.63Cr -388.63Cr -39Cr -15Cr -194.37Cr -15Cr -15Cr -647.43Cr -6.18Cr -4.39Cr -3.79Cr -3.56Cr -3.24Cr -6.09Cr -420.15Cr -42Cr -16Cr -210.13Cr -16Cr -16Cr -699.93Cr
Logo Cogstate Limited
Cogstate Limited is a neuroscience technology company optimizing brain health assessments to advance the development of new medicines and to enable earlier clinical insights in healthcare. Its principal activities are the creation, validation, and commercialization of digital brain health assessments; and design and provision of quality assurance services in clinical trials, focused on the administration, scoring, and recording of conventional brain health assessments. Its segments include Clinical Trials, Healthcare, and Administration. In the Clinical Trials segment, the technology and associated services are used to quantify the effect of disease and of drugs, devices or other interventions on human subjects participating in clinical trials primarily conducted by pharmaceutical, and biotechnology companies. In the Healthcare segment, the technology and associated services are being developed as a tool for primary care physicians and/or hospitals to assess cognitive decline.
Employees
160
Date Price Change Volume
19/26/19 A$2.905 +6.41% 14,01,808
18/26/18 A$2.730 -2.15% 32,21,236
17/26/17 A$2.790 -0.36% 5,69,868
14/26/14 A$2.800 +2.19% 12,92,674
13/26/13 A$2.740 -0.36% 8,49,793
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
2.730AUD
Average target price
3.570AUD
Spread / Average Target
+30.77%

Quarterly revenue - Rate of surprise